The IQGAP1-Claudin4-JNK Signaling Axis as a Differential Biomarker in Renal Cell Carcinoma

IQGAP1-Claudin4-JNK信号轴作为肾细胞癌的差异性生物标志物

阅读:1

Abstract

Renal cell carcinoma (RCC) is a highly heterogeneous malignant neoplasm with multiple morphological and molecular subtypes; however, the basis of this heterogeneity remains incompletely defined, hindering effective diagnosis and treatment. The signaling scaffold IQGAP1 and claudins are tight junction protein partners involved in epithelial cell polarity and polarized secretion whose overexpression has been associated with RCC, though the molecular mechanism is obscure. RNA-seq data on the TCGA database shows that the RNA expression levels of IQGAP1 and claudin-2, -4, and -8 differentially change significantly in normal versus RCC tumors, suggesting a regulatory loop between IQGAP1 and each of these claudins. Previously, we reported that IQGAP1 differentially regulates claudin -2 and -4 localization and expression at the tight junctions and imparts on kidney epithelial structure and function. Here, we show that IQGAP1 localization, and not mere expression level, accompanies RCC phenotypes and differential expression of several junctional proteins where claudin-4 localization remains intact or stabilized. Notably, IQGAP1 expression appears inversely correlated with that of claudin-4, supporting a dynamic interaction at the tight junctions. These findings support the notion that IQGAP1 localization influences claudin dynamics, and its dysfunction imparts on RCC. Altogether, these findings pave the way for exploring the differential expression and localization of the IQGAP1/claudin complex as personalized diagnostics or therapeutics to address RCC heterogeneity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。